-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"
Pharmaceutical Network Industry Dynamic" Recently, Jiangsu Pharmaceutical Mining Platform issued a notice to suspend the results of drug classification processing on the internetAccording to the circular, of the 5,336 drugs, in addition to 18 drugs resumed hanging nets, the remaining 5,318 drugs were suspended or removedAmong them, including omeprazole, oxalate, ntikave, yew alcohol, kramycin, hydrochloric acid sitliline, ebesatin, cold sequins and other larger and more common varietiesAt the request of Zhejiang Public Resources Trading Center, the results will be implemented on August 1next month, thousands of drugs will be kicked out of the market
specifically, Jiangsu Province this suspension of the network action can be traced back to 2019 In Jiangsu Province on the collection of catalog drug prices for dynamic adjustment periodAmong them, it is worth noting that Jiangsu Province requires price adjustment of drugs not only 4 plus 7 in the expansion of the unselected products, including the 2015 Jiangsu Province collection of drugs, involving a very wide rangein addition to, from Jiangsu Province this hanging network notice and in recent years, the suspension of the suspension of the internet drug notice, price reduction is not in place and did not have a consistency evaluation and withdraw the hanging network situation is becoming a large number of drugs are being kicked out of the hospital market the main reasonAs on April 13, the Beijing Municipal Pharmaceutical Collection and Collection Service Center issued a Notice on the Suspension of Some of the Product Procurement Functions of The National Collection and Acquisition That failed to pass the Consistency Evaluation Function844 drugs were suspended on the net, the varieties are both 4 plus 7 varieties, but also the second round of national mining and expansion of the varieties, a total of 844, involving a number of well-known pharmaceutical companiesJune 18, Anhui Province Pharmaceutical Centralized Purchasing Network issued a notice on the suspension of the Alliance Region (Anhui Province) drug centralized procurement of varieties related to drug network qualificationNotice content pointed out: According to the "on the public suspension of procurement part of the non-pass edified drug quality and efficacy consistency evaluation of drugs notice" and "on the development of the alliance region (Anhui Province) drug centralized procurement of drug-related drug joint price reduction work" documents, including Ubersatan tablets, Reinoply tablets, chloratan potassium tablets, Malay acid Inapri tablets, including 228 batches, 30 production enterprises were suspended hanging network qualification, which involves the Yangjiang Pharmaceutical Industry, etc in fact, with the third round of national and local collection, consistency evaluation and price linkage has become more and more pressure on pharmaceutical companies And from the current measures of Jiangsu Province on more than 10,000 products, pharmaceutical companies in the hospital is increasingly squeezed, with some areas of drugstores into the collection and not selected products in the action outside the hospital, the space outside the market is expected to be more intense it is understood that earlier the State Health Insurance Administration has internal documents outflow, will be the total budget, balance retained on the basis of the reform of medical insurance payment, to encourage medical institutions to give priority to the use of national selected drugs In the case of drugs have become a cost item, the industry analysis, even through price reduction and other means in the link to keep the market in the market of the unselected medicine, in the clinical use of the link, or will be marginalized and lost the market in general, under a series of policies, such as consistent evaluation, regularization of volume procurement and improvement of drug quality standards, more and more inefficient, backward production capacity and non-compliant drugs will be phased out in bulk Among them, the price will gradually become an important factor after the consistency evaluation and then the elimination of varieties In addition, the phased varieties will also be quickly to the national collection of varieties outside.